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ABSTRACT
Volatile anesthetics can cause neuronal and glial toxicity in the developing mammalian brain, as well as long-term defects
in learning and memory. The goals of this study were to compare anesthetics using a clinically relevant exposure paradigm,
and to assess the anesthetic effects on hippocampal development and behavior. Our hypothesis was that volatile
anesthetics disrupt hippocampal development, causing neurobehavioral defects later in life. Bromodeoxyuridine (BrdU)
was administered to rats on postnatal day (P)1, and the rats were exposed to volatile anesthetics (isoflurane, sevoflurane, or
desflurane) for 2 h on P2. On days P7 and P14, the BrdU-labeled cells were quantified in the hippocampal dentate gyrus using
immunohistochemical assays and fluorescent microscopy. Caspase-3 positive cells were quantified on P2 to evaluate
apoptosis. The remaining animals underwent behavioral testing at ages 6 weeks and 6 months, using the Morris Water
Maze. Significantly fewer BrdU-positive cells were detected in the hippocampal dentate gyrus in both isoflurane and
desflurane-treated animals compared with controls at P7, but there were no changes in cell numbers after sevoflurane
exposure. Cell counts for all three anesthetics compared with controls were equivalent at P14. Isoflurane or desflurane
exposure yielded slight differences in the behavioral tests at 6 weeks, but no differences at 6 months post-exposure. We
conclude that a single 2-h exposure at P2 to either isoflurane or desflurane causes a transient disruption of hippocampal
neuronal development with no significant detectable long-term effects on learning and memory, whereas the same
exposure to sevoflurane has no effects.
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Children receive general anesthesia frequently for both surgical
and nonsurgical procedures, and concern has been raised that
the anesthetics themselves may be harmful to the developing
brain. Human studies have focused on various outcomes, in-
cluding rates of behavioral disorders (DiMaggio et al., 2009, 2011;
Flick et al., 2011; Ing et al., 2012; Kalkman et al., 2009), learning
disabilities (Flick et al., 2011; Wilder et al., 2009), ADHD (Sprung
et al., 2012), language ability (Ing et al., 2012), and cognitive per-
formance (Bartels et al., 2009; Flick et al., 2011; Ing et al., 2012).
While these studies have produced mixed results, most sug-
gested that children who underwent multiple anesthetics had a
greater likelihood of being diagnosed with a behavioral or cogni-
tive problem (DiMaggio et al., 2009, 2011; Flick et al., 2011; Ing
et al., 2012; Kalkman et al., 2009; Sprung et al., 2012; Wilder et al.,
2009).
Animal studies have shown that exposure to volatile anes-
thetics alone can cause neuronal and glial toxicity in the devel-
oping mammalian brain, as well as defects in learning,
memory, and behavior. These toxic effects could be due to dis-
ruption of different developmental processes. For example, sev-
eral groups have studied apoptosis rates following an
anesthetic exposure, and have shown more apoptosis in the
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brains of exposed animals (Brambrink et al., 2010, 2012;
Istaphanous et al., 2011; Jevtovic-Todorovic et al., 2003; Liang
et al., 2010; Yang et al., 2014; Zou et al., 2011). Furthermore, anes-
thetic exposure has been shown to affect neurogenesis
(Stratmann et al., 2009b; Zhu et al., 2010) and neuroinflammation
(Shen et al., 2013) in the developing rat brain. A combination of
general anesthetics was also shown to impair mitochondrial
morphogenesis and synaptic transmission during rat brain de-
velopment (Sanchez et al., 2011). Cell culture studies have
shown that anesthetic exposure impairs axonal guidance cues
(Mintz et al., 2013) and disrupts cytoskeletal structure in astro-
glia (Lunardi et al., 2011).
Behavioral studies in animals have produced mixed results.
Some groups have shown that rats have impaired learning and
memory in various behavioral tests after anesthetic exposure
(Jevtovic-Todorovic et al., 2003; Shen et al., 2013; Stratmann et al.,
2009b; Zhu et al., 2010). However, others have reported that even
though exposed animals had increased apoptosis, there were
no differences in behavior after anesthesia (Liang et al., 2010;
Yang et al., 2014).
These studies have given us important information about
how anesthetics may disrupt brain development, but there are
many developmental processes that have not been studied. The
sequence of events for brain development includes prolifera-
tion, migration, differentiation, synaptogenesis, myelination,
and apoptosis (Altman and Bayer, 1975; Angevine, 1975; Bayer
et al., 1993). Neuronal proliferation, migration and differentia-
tion are important early developmental processes required for
neurons to form their correct synaptic connections. In the de-
veloping rat brain, these events occur prenatally in most brain
regions; however, in the dentate gyrus of the hippocampus,
neuronal proliferation, migration and differentiation continues
postnatally (Altman and Bayer, 1975; Angevine, 1975; Bayer
et al., 1993). In the neonatal rat, immature neurons proliferate in
the subgranular zone (SGZ) of the hippocampus and then mi-
grate along radial glial cells to their final positions in the granu-
lar layer of the dentate gyrus (Altman and Bayer, 1975;
Angevine, 1975; Bayer et al., 1993; Corbin et al., 2008; Eckenhoff
and Rakic, 1984; Rickmann et al., 1987). Given that prior studies
have focused on synaptogenesis and apoptosis at postnatal day
(P) 7, we believe it is important to examine the earlier events of
neuronal proliferation and migration.
Prior animal studies have used combinations of anes-
thetics (Jevtovic-Todorovic et al., 2003; Sanchez et al., 2011;
Zou et al., 2011), anesthetics at relatively high doses (Shen
et al., 2013), or long anesthetic exposures (Brambrink et al.,
2012; Istaphanous et al., 2011; Liang et al., 2010; Shih et al.,
2012; Stratmann et al., 2009b), potentially introducing physio-
logic changes (such as hypercarbia) not present in pediatric
patients. Furthermore, most prior studies have exposed ro-
dents to anesthetics on P7 (Istaphanous et al., 2011; Jevtovic-
Todorovic et al., 2003; Liang et al., 2010; Shen et al., 2013;
Stratmann et al., 2009b; Yang et al., 2014; Zhu et al., 2010), and
have provided invaluable information regarding the effects
of anesthetic exposure at this very important time point in
rodent brain development. Children of all ages receive anes-
thesia, so we must continue to study the effects of anes-
thetics at multiple developmental stages in rats as well. We
chose to expose rats to anesthetics on P2 in order to gain new
information about how anesthetics affect neurodevelopment
at this earlier time point. We also used lower concentrations
of anesthetics and shorter exposures than many other stud-
ies to more closely mimic clinical practice. We compared
three clinically used anesthetics (isoflurane, sevoflurane,
and desflurane) to identify differences in their toxicity pro-
files. We hypothesized that volatile anesthetics would dis-
rupt hippocampal development, causing neurobehavioral
defects later in life.
MATERIALS AND METHODS
Animal care. The animal protocol was approved by the University
of Pennsylvania Institutional Animal Care and Use Committee
(IACUC) and all rats were treated in strict accordance with APS/
NIH guidelines. Timed pregnant female Sprague–Dawley rats
(Charles River, Horsham, Pennsylvania) and litters were housed
at the animal facilities at the University of Pennsylvania. The
birth date of the pups was considered to be P0.
BrdU injections. On P1, all pups, except the group euthanized at
P2 for caspase-3 immunohistochemistry, were given two intra-
peritoneal (i.p.) injections of 5-bromo-20-deoxyuridine (BrdU)
(Sigma–Aldrich B5002, St. Louis, Missouri) 50 mg/kg, 4 h apart.
The average weight of rats on P1 was 7.23 g. BrdU solution
(5 mg/ml) was made using sterile saline and NaOH for pH neu-
tralization to 7.4, filtered using a 0.2-mm filter in a sterile hood,
and stored at 20C. The animals were immediately returned to
the cage with the mother after each injection, and resumed nor-
mal feeding behavior.
Anesthetic exposures. On P2, rat pups from a total of 18 litters
were randomly divided into treatment and control groups and
anesthetized with isoflurane, sevoflurane, or desflurane for 2 h.
Sex was not determined at this age. As previously described
(Liang et al., 2010), an anesthetic chamber setup was used. The
Plexiglas anesthetic and control chambers were placed in a
fume hood and kept partially submerged in a 44 C 61C water
bath, resulting in the air temperature just above the chamber
floor being 30 C 6 1C, which has been shown to maintain
physiologic temperatures in P7 mice. Controls and anesthetized
groups received heated and humidified 30% oxygen balanced
with nitrogen at a total oxygen plus air flow rate of 4 L/min for
the duration of the experiment, with all groups having maternal
separation in the Plexigas chambers for the duration of the 2-h
exposure. Continuous chamber anesthetic gas, oxygen, and car-
bon dioxide concentrations were measured with gas analyzers
(Ohmeda 5330 Agent Monitor, Ohmeda, Louisville, Colorado;
Capnomac Ultima, Datex–Engstrom, Helsinki, Finland) during
the 2-h exposures for control and experimental groups. Carbon
dioxide concentrations remained at 0% for all experiments, as is
expected for this experimental setup using a relatively high gas
flow rate and large chamber compared with animal size. This
setup prevents accumulation of exhaled CO2 and effectively
maintains a steady state of all gases in the chamber.
Postnatal day 2 pups in the treatment groups were induced
(determined by loss of righting reflex and loss of tail clamp
response in>50% of the animals) with either 3.5% isoflurane for
5 min and maintained at 1.5% isoflurane for the remainder of
the exposure, 5% sevoflurane and maintained at 2.5%, or 12%
desflurane and maintained at 7%. The concentrations chosen
for maintenance were based on prior work in P7 rats showing
that the minimum alveolar concentration (MAC) at the 2-h time
point during an anesthetic exposure was 2.0% for isoflurane,
3.3% for sevoflurane, and 9.2% for desflurane (Stratmann and
Alvi, 2011). These doses are also supported by prior work in P2
rats showing that the MAC for isoflurane is 1.9%, and the MAC
for sevoflurane is 3.3% (Orliaguet et al., 2001), which correlates
exactly with the data for P7 rats. We chose to use an anesthetic











ill Libraries user on 17 August 2019
concentration equivalent to 0.75 MAC, which is clinically rele-
vant in the neonatal age group, and also results in very low
mortality. During the exposures, animals were constantly
observed for changes in skin color and chamber oxygen/carbon
dioxide concentrations. The respiratory rate and response to
tail pinch were monitored every 30 min by briefly opening the
chamber. The anesthetic concentration and air/oxygen flows
were then briefly increased until the concentration in the cham-
ber returned to 0.75 MAC. In addition, at the end of the 2-h anes-
thetic exposures, while still under anesthesia, a subset of
animals was used to obtain arterial blood for determination of
arterial blood gas (ABG) data via blind direct left ventricular
puncture, a terminal procedure commonly used in neonatal
rats (Jevtovic-Todorovic et al., 2003; Liang et al., 2010; Shih et al.,
2012; Stratmann et al., 2009a,b). Blood was collected in hepari-
nized 1-cc syringes and immediately analyzed in a blood gas
analyzer (Siemens RAPIDLab 248, Malvern, Pennsylvania). We
obtained ABGs from control rat pups by anesthetizing them
with isoflurane for 15–20 min (until no response to tail clamp)
prior to this procedure. Bright red blood was determined to be
arterial blood, but a limitation of this blind procedure is that the
source of blood cannot be verified. There were no statistically
significant differences in pH, partial pressure of carbon dioxide
(pCO2), or partial pressure of oxygen (pO2) for each anesthetic
group compared with control (Table 1). The remaining animals
were removed one at a time from the anesthetic chamber and,
prior to emergence from anesthesia, immediately microtat-
tooed with one dot on the paw or base of tail (in <15 s) with
Ketchum animal tattoo paste (Braintree Scientific, Braintree,
Massachusetts) using an Aramis microtattoo kit (Braintree
Scientific) with a 26 1=2 G needle for later identification. The rat
pups for the caspase-3 study were not tattooed because they
were immediately euthanized and could be identified with a
sharpie pen. Microtattoo is the least noxious marking techni-
que, with microtattoed animals having significantly lower heart
rate and blood pressure than animals that were given ear tat-
toos or ear notching (Kasanen et al., 2011). Furthermore, the
more traumatic practice of tail biopsy for genotyping has no
effect on pain behaviors (Morales and Gereau, 2009). These stud-
ies suggest that the less invasive technique of microtattooing
likely had no effect on behavior, apoptosis, or cell counts in our
study.
After the 2-h exposures, the animals were removed from the
anesthetic chamber and placed on disposable chucks over a
heating pad (surface temperature 37C) to recover. Mortality
from the exposures were: control 0%, isoflurane 3.8%, sevoflur-
ane 5.3%, and desflurane 4.8% (not statistically significant,
P¼ .35). These are very low when compared with similar studies
reporting 21%–25% mortality after a 4-h anesthetic exposure
(Istaphanous et al., 2011; Stratmann et al., 2009a). We hypothe-
sized that death occurred in this small subset of animals
because of respiratory depression leading to hypoxia and/or
hypercarbia, though we did not perform any analysis to test this
hypothesis. When the animals had fully recovered from anes-
thesia as evidenced by coordinated locomotion (after
approximately 15 min), they were returned to cages with their
mothers and resumed normal feeding behavior.
Tissue preparation and immunohistochemistry. Rats were euthanized
on P2, P7, or P14, or after the second round of behavioral studies at
7 months of age. The animals were deeply anesthetized with the
anesthetic corresponding to their exposure and perfused through
the left cardiac ventricle with phosphate buffered saline (PBS, pH
7.4) with right atrial exsanguination, followed by perfusion with
cold 4% paraformaldehyde. The brains were removed and post-
fixed in 4% paraformaldehyde at 4C for 1–3 days. The brains were
then dehydrated, paraffin-fixed, and embedded in paraffin blocks
for sectioning. Serial coronal sections were cut using a microtome
set to 8 mm and adhered to glass slides.
Newly formed cells in the subgranular zone (SGZ) of the den-
tate gyrus differentiate and migrate to the granule cell layer
over the course of days to weeks (Angevine, 1975). Therefore, in
order to study the effects of anesthetic exposures on neuronal
proliferation and migration in the hippocampal dentate gyrus,
immunohistochemistry was performed on P2 (caspase-3 only),
P7, and P14 brain sections, as described previously (Peng et al.,
2014; Zhu et al., 2010), with minor modifications as follows. The
sections were deparaffinized in xylenes, then rehydrated using
serially decreasing ethanol concentrations. Antigen retrieval
was carried out in a decloaking chamber (Biocare Medical
DC1509, Concord, California) with the tissue submerged in
sodium citrate buffer 10 mM, pH 6.0, for 2 min with a maximum
pressure of 30 psi and maximum temperature of 125C, followed
by depressurization and cooling. Blocking buffer (0.1 M PBS,
0.3% Triton X-100, 2% goat serum) was applied to the tissue for
60 min. The sections were incubated with primary antibodies
overnight at 4 C (Table 2), followed by incubation with the sec-
ondary antibody (Table 2) for 2 h at room temperature. All sec-
tions were coverslipped using Prolong Gold Anti-Fade Reagent
(Life Technologies P36930, Carlsbad, California) mounting
medium, except for the caspase-stained slides, which were cov-
erslipped using ProLong Gold Anti-fade Reagent with DAPI (Life
Technologies P36931) mounting medium.
Imaging. Quantitative imaging was performed by an investigator
blinded to the treatment groups using sections chosen from
each brain starting at the anterior hippocampus, corresponding
to figure 57 (page 61) of the Atlas of the Neonatal Brain
(Ramachandra and Subramanian, 2011), and using every 10th
section thereafter for a total of five coronal sections per brain,
allowing us to capture cells throughout the dentate gyrus.
Fluorescence microscopy was performed using an Olympus
BX41 microscope equipped with a digital camera (QImaging,
Surrey, British Columbia, Canada) and computer running IPLab
software (Scanalytics, Scientific Instrument Company,
Campbell, California) for image capture.
TABLE 1. Arterial Blood Gas Analysis
Control (n¼6) Desflurane (n¼4) Sevoflurane (n¼8) Isoflurane (n¼6) P value
pH 7.3160.02 7.3260.02 7.2160.03 7.2060.04 0.0562
pCO2 65.2264.29 49.3567.03 60.0966.05 71.0066.05 0.3025
pO2 62.4863.95 57.2363.14 74.25613.43 52.3564.60 0.5093
Data are expressed as means 6 SEM.
P values for each blood gas parameter from one-way ANOVA of anesthetic exposures compared with control.
pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen.
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For BrdU immunohistochemistry, the rat pup brains from
each treatment group at P7 and P14 were examined using a 10
objective and imaged for BrdU and NeuN (neuronal nuclear
antigen), or BrdU and Tuj1. While both neuronal markers, NeuN
and Tuj1 (neuron-specific class III beta-tubulin), provided
adequate staining of neurons to identify the structure and
layers of the hippocampus in all sections, neither showed defin-
itive co-localization with BrdU at P7 or P14 for quantitative pur-
poses. It is possible that these BrdU-positive cells were too
young to adequately express either neuronal marker. The
regions of interest in the dentate gyrus (outer and inner halves
of the granular layer (GCL), and subgranular zone (SGZ, includ-
ing the hilus) were first traced on each image using Adobe
Photoshop software (Adobe Systems, San Jose, California) using
only the filter corresponding to the NeuN or Tuj1 staining, both
of which provided an anatomical map for neuronal layers and
also kept the investigator blinded to the location of BrdU-
positive cells. Then, the number of BrdU-positive cells in each
region per unit area were counted using only the filter for BrdU
staining with ImageJ software (NIH, http://imagej.nih.gov/ij/
index.html, last accessed on 30 August 2016). The mean number
of BrdU-positive cells was calculated from five to six brain sec-
tions for each animal, n¼ 3 animals for each group at both ages.
In summary, we injected P1 rats with BrdU to label cells
formed on P1, and the rat pups were exposed to volatile anes-
thetics on P2. BrdU-positive cells were counted at two time
points (P7 and P14) in the dentate gyrus, with representative
images shown in Figure 1.
In order to examine whether differences in the BrdU-
positive cell counts may have been due to apoptosis caused by
the anesthetic exposures, we performed activated caspase-3
immunohistochemistry on hippocampal sections obtained
from P2 rats sacrificed immediately after the 2-h anesthetic
exposures. For caspase-3 immunohistochemistry, P2 caspase-
stained slides from each treatment group were imaged at 20,
and the number of caspase-3 positive cells per area were
counted as described above for BrdU, first tracing the combined
GCL and SGZ under the DAPI filter and then using ImageJ soft-
ware (NIH, http://imagej.nih.gov/ij/index.html, last accessed on
30 August 2016) to count the caspase-3 positive cells. The mean
number of caspase-3 positive cells was calculated from five to
six brain sections for each animal, n¼ 5 animals for each group.
Morris water maze. Rat pups were allowed to mature for behavio-
ral testing in the Morris water maze (MWM) at 6 weeks and
6 months of age (n¼ 12). A total of 48 rats were used for the
behavioral experiments, including both male (M) and female (F)
rats, randomly divided among the experimental groups. The
sex of the rats per group were as follows: control 6 M and 6 F,
isoflurane 4 M and 8 F, sevoflurane 4 M and 8 F, and desflurane
4 M and 8 F. The same cohorts of animals were used at both
time points.
We performed behavioral testing using the MWM, which has
been used in many prior studies (Jevtovic-Todorovic et al., 2003;
Liang et al., 2010; Shih et al., 2012; Stratmann et al., 2009a,b) for
evaluation of hippocampal-dependent learning and memory.
The MWM testing was performed as previously described
(Vorhees and Williams, 2006), with minor modifications. The
pool was 150 cm in diameter, the platform was 15 cm in diame-
ter, the water was deep enough to cover the platform by 1–2 cm,
and the water temperature was kept at 24C 62C. The water was
opacified with a small amount of titanium oxide and nontoxic
blue paint in order to provide contrast to the white rats, and the
sides of the pool were labeled with the cardinal directions (north,
south, east, and west) in order to define locations for the plat-
form and for placing animals into the pool. The testing area was
equipped with a video camera mounted above the pool and
WaterMaze3 imaging software (Coulbourn Instruments,
Whitehall, Pennsylvania), which recorded the animals’ swim
path length, duration (escape latency), and swim speed. After
each trial in the pool, the animals were placed in a heated recov-
ery chamber and then returned to their home cages.
Cued training was conducted first, with a white curtain sur-
rounding the pool, consisting of four trials per day for 5 days,
and served the purposes of training the rats to swim to a flagged
platform and controlling for visual and motor impairments.
Then place trials were performed, also consisting of four trials
per day for 5 days, in order to measure spatial reference mem-
ory. Twenty-four hours after the fifth day of place trials, a 60-s
probe trial was conducted to test memory retention.
Statistical analysis. Mortality was compared among groups using
v2 contingency table analysis. ABG data were analyzed using
the Kruskal–Wallis test for nonparametric data (one-way
ANOVA) with Dunn’s multiple comparison test for each of the
three blood gases (Table 1). For the BrdU-positive cell counts,
two-way ANOVAs with Sidak’s multiple comparison tests were
performed to determine differences between anesthetic expo-
sure groups in the three defined regions of the dentate gyrus
(Figs. 2A–C). The caspase-3 cell counts (Figure 3) and the MWM
swim speeds (Figs. 4D and 5D) were analyzed using the Kruskal–
Wallis ANOVA with Dunn’s multiple comparisons tests, and the
two-way ANOVA with Sidak’s multiple comparisons test was
used for the MWM probe data (Figs. 4C and 5C). Statistical
analysis for the MWM escape latencies (Figs. 4A and B and 5A
and B) used a two-way repeated measures ANOVA with
TABLE 2. Antibodies
Raised against Supplier (ID) Raised in Dilution Corresponding secondary
antibody
BrdU Serotec (MCA2060) Rat, monoclonal 1:1000 Alexa Fluor 594 goat anti-rat
IgG (A11007)
NeuN Millipore (MAB377) Mouse, monoclonal 1:500 Alexa Fluor 488 goat anti-mouse IgG
*highly cross adsorbed* (A11029)
Tuj1 Covance/BioLegend (MMS-435P) Mouse, monoclonal 1:500 Alexa Fluor 488 goat anti-mouse IgG
*highly cross adsorbed* (A11029)
Cleaved caspase-3 Cell Signaling (Asp175) (5A1E) Rabbit, monoclonal 1:500 Alexa Fluor 594 goat anti-rabbit IgG
*highly cross adsorbed* (A11037)
BrdU, bromodeoxyuridine; NeuN, neuronal nuclear antigen; Tuj1, neuron-specific class III beta-tubulin.











ill Libraries user on 17 August 2019
Bonferroni multiple comparisons tests, and nonlinear regres-
sion was performed fitting the data to a third order polyno-
mial equation to compare the shape of the curve associated
with each anesthetic. Exact P values adjusted for multiple cor-
rections are reported in the “Results” section and Table 1. In
the figures, the P values are reported as inequalities, with
P< .05 considered significant. The data were expressed as the
means 6 SEM and statistical analyses were performed using
GraphPad Prism v6.0 software (GraphPad Software, Inc, La
Jolla, California).
FIG. 1. Immunohistochemistry for BrdU positive cells in the dentate gyrus. A–D, Representative images at P7 showing BrdU labeled cells (red) and NeuN labeled cells
(green) for control (A), isoflurane (B), sevoflurane (C), and desflurane (D). E–H, Representative images at P14 showing BrdU labeled cells (red) and NeuN labeled cells
(green) for control (E), isoflurane (F), sevoflurane (G), and desflurane (H). Scale bar, 50 microns.
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RESULTS
Fate of Neurons Exposed to Anesthetics on Postnatal Day 2
At P7 and P14, we examined the number of cells per area in the
SGZ and the inner and outer halves of the granule cell layer of
exposed animals compared with controls. At P7, we saw signifi-
cantly fewer BrdU-positive cells in the inner granular layer (IGL)
and the outer granular layer (OGL) of the dentate gyrus for both
isoflurane- (P¼ .0068 and P¼ .0078, respectively) and desflurane-
(P¼ .0002 and P¼ .0028, respectively) exposed rats compared
with controls in the post hoc analysis (Figure 2A). There were no
significant differences in the number of BrdU-positive cells seen
in the IGL or OGL in the sevoflurane-exposed rats compared
with controls (P> .9999, P¼ .9482, respectively) (Figure 2A).
Furthermore, there were no differences in the number of BrdU-
positive cells in the SGZ between controls and isoflurane
(P¼ .8210), sevoflurane (P¼ .8426), or desflurane (P¼ .6702)
(Figure 2A). At P14, there were no significant differences
between cell counts in the IGL (P> .9999, P> .9999, P¼ .9560),
OGL (P¼ .7834, P¼ .4490, P¼ .9994), and SGZ (P¼ .9932, P¼ .9691,
P¼ .9874) for isoflurane, sevoflurane and desflurane (respec-
tively) compared with controls (Figure 2B).
When we analyzed the total number of BrdU-positive cells in
all areas of the dentate at P7 and P14, we found a significant
interaction (P¼ .0046). At P7, multiple comparison tests showed
statistically fewer BrdU-positive cells after exposure to isoflur-
ane (P¼ .0134) and desflurane (P¼ .0019) compared with controls
(Figure 2C), but no difference in cell counts after sevoflurane
exposure (P¼ .9994). At P14, there were no significant differen-
ces between total BrdU-positive cells in the dentate for all anes-
thetics compared with controls (isoflurane P¼ .9607,
sevoflurane P¼ .9854, desflurane P¼ .9898) (Figure 2C). In addi-
tion, there were significantly fewer BrdU-positive cells at P14
compared with P7 for the control and sevoflurane groups
(P¼ .0005 and P¼ .0003, respectively), but not for the isoflurane
and desflurane groups (P¼ .0807 and P¼ .2644, respectively)
(Figure 2C).
Cell Death After Anesthetic Exposures on Postnatal Day 2
There were no significant differences detected in the number of
activated caspase-3 cells/area between the isoflurane (P¼ .5443),
sevoflurane (P> .9999), or desflurane (P> .9999) exposed groups
and controls (Figure 3) in the dentate gyrus at P2.
Long-Term Cognitive Effects of an Anesthetic Exposure on Postnatal
Day 2
At 6 weeks post-exposure, there was no significant interaction
between treatment groups and controls for the cued training
(P¼ .3064) (Figure 4A). This implies that all animals were able to
visually locate the platform and learn to “escape” from the pool
by reaching the platform. During the place trials, in which the
animals must find a hidden platform, a significant interaction
was detected in the escape latencies between the treatment
groups and controls (P< .0001) (Figure 4B). Nonlinear regression
analysis for each anesthetic showed that only the isoflurane
group was significantly different from controls (P< .001).
Multiple comparison tests showed that rats exposed to isoflur-
ane or desflurane took significantly longer (P< .0001 and
FIG. 2. Quantitative analysis of BrdU-positive cell counts in the dentate gyrus.
Number of BrdU positive cells per mm2 in the subgranular zone (SGZ), inner gran-
ular layer (IGL), and outer granular layer (OGL) of the hippocampus. A, At P7, sig-
nificantly fewer BrdU cells were located in the IGL and OGL in the isoflurane and
desflurane exposed groups compared with controls (**P< .01, ***P< .001). B, At
P14, no differences were detected. C, Comparison of total BrdU-positive cell
count including all areas at P7 showed significantly fewer BrdU cells at P7 in the
isoflurane and desflurane groups (*P< .05, **P< .01). Total BrdU-positive cell
counts including all areas at P14 were equivalent. When comparing P7 to P14 for
each anesthetic, there were significantly fewer total BrdU cells including all
areas in the control and sevoflurane groups at P14 compared with P7 (***P< .001).
Data are expressed as means 6 SEM. (Con¼ control, Iso¼ isoflurane,
Sevo¼ sevoflurane, Des¼desflurane; n¼3 for each group).
FIG. 3. Cleaved caspase-3 immunohistochemistry at P2 in the dentate gyrus.
The number of cleaved caspase-3 positive cells/area was not significantly differ-
ent in the anesthetic groups compared with controls. Data are expressed as
means 6 SEM. (Con¼ control, Iso¼ isoflurane, Sevo¼ sevoflurane,
Des¼desflurane; n¼5 for each group).
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P¼ .0002, respectively) to reach the platform on day three of
testing (Figure 4B), but that all animals generally learned to
escape from the pool with the same latency by day 5. Twenty-
four hours after the fifth day of place trials, the probe trial was
performed with the expectation that the rats would spend more
time in the target quadrant searching for the platform. No sig-
nificant interaction was detected in quadrant time and anes-
thetic exposure (P¼ .0793) (Figure 4C) and post hoc analyses also
found no significant differences between anesthetic exposures
and time spent in each quadrant. The swim speed of the ani-
mals, calculated during the probe trial, showed that the
desflurane-treated animals were significantly faster than con-
trols (P¼ .0008), but all other treatment groups were equivalent
in swim speed (P¼ .0545 for isoflurane, P¼ .8615 for sevoflurane)
(Figure 4D).
The MWM testing was repeated at 6 months after the expo-
sures. There was no significant interaction between treatment
groups during the cued training (P¼ .1957) (Figure 5A), or during
the place trials (P¼ .4694) (Figure 5B). Twenty-four hours after the
last place trials, the probe trial was performed, and there were no
significant differences between anesthetic exposures and time
spent in each quadrant (P¼ .0710) (Figure 5C). Post hoc analyses
also failed to detect any significant differences between anes-
thetic exposures and time spent in each quadrant. There was no
significant interaction between swim speed and the treatment
groups compared with controls (P¼ .0616) (Figure 5D).
DISCUSSION
Our data indicate that inhalational anesthetics cause a transi-
ent disruption of normal neuronal development in the dentate
gyrus (DG) of the hippocampus, but no long-term cognitive
impairment was detected using the MWM. Furthermore, not all
inhalational anesthetics tested produced this effect, each hav-
ing its own neuromodulatory profile.
At P7, we found fewer BrdU-labeled cells in the granular
layer of the DG after isoflurane and desflurane exposure, but
not after sevoflurane exposure. The relative decrease in cell
counts at P7 did not appear to be because of anesthetic-induced
apoptosis occurring immediately after the exposure, as we saw
no differences in caspase-3 staining at P2 between any
anesthetic-exposed animals and controls. However, it should be
noted that by performing caspase-3 staining immediately fol-
lowing the 2-h anesthetic exposure, the apoptosis cascade may
not have reached its peak. Although the peak may indeed come
several hours after the anesthetic exposure (Cheng et al., 2015;
Konno et al., 2016), others have shown caspase-3 activation
immediately after a 1-h exposure to isoflurane (2%) in the P7
mouse retina (Cheng et al., 2015), or immediately after a 2-h
exposure to a cocktail of midazolam, nitrous oxide (75%), and
isoflurane (0.75%) in the P7 rat thalamus (Yon et al., 2005).
Therefore, if apoptosis were explaining the differences in BrdU
cell counts at P7, we would likely have detected it immediately
after the exposure at P2.
FIG. 4. Morris water maze results at 6 weeks after anesthetic exposure. A, Cued training showed no significant interaction in escape latencies. B, Place trials showed a
significant interaction of anesthetic exposure on the learning curve, and nonlinear regression analysis confirmed this effect with isoflurane exposure. Post hoc analyses
also detected significantly slower escape latencies on day 3 for both the isoflurane and desflurane groups (***P< .001). C, No significant differences in the anesthetic
exposed rats compared with controls were detected for the probe test. (quadrants: AdjL, adjacent left; Tar, target; AdjR, adjacent right; Opp, opposite). D, Swim speed
was significantly faster in the desflurane group (***P< .001). (Con¼ control, Iso¼ isoflurane, Sevo¼ sevoflurane, Des¼desflurane.) Data are expressed as means 6 SEM;
n¼12 for each group, except in 5C, where Con n¼11 because of a technical error.











ill Libraries user on 17 August 2019
At P14, all groups were comparable but had significantly
lower BrdU counts than at P7. This suggests that, in contrast to
the P2–7 interval, where proliferation and migration were pri-
marily responsible for the relatively higher cell counts, changes
during the P7–14 interval were primarily due to normal develop-
mental apoptosis. It is interesting to note that these normal
mechanisms appeared to compensate for the early anesthetic-
induced changes in proliferation and/or migration in the isoflur-
ane and desflurane groups.
Our immunohistochemical results suggest that isoflurane
and desflurane alter neuronal development by decreasing the
number of neurons that have reached the granular layer of the
DG by P7. This change could be because of anesthetic effects on
cell proliferation, division, or migration. If it were an isolated
effect on migration, we would have expected the BrdU-labeled
cells in the isoflurane and desflurane groups to be increased at
P7 in the SGZ, where these neurons are “born.” However, this
did not occur, as all anesthetic groups and controls had similar
SGZ cell counts. An alternate explanation is that anesthetic
exposure caused the BrdU-labeled neurons in the SGZ to have
both impaired division and impaired migration to the granular
layer. We know that neurons in the DG have the ability to con-
tinue to divide into adulthood (Mathews et al., 2010), and that
BrdU incorporated during DNA synthesis is passed down to
daughter cells in subsequent divisions (Wojtowicz and Kee,
2006). Therefore, we interpret our data to mean that BrdU-
positive progenitor cells were transiently delayed in the SGZ at
P7, but that these cells regained the ability to divide and migrate
between P7 and P14, resulting in the normal number of neurons
in the granular layer at P14. The fact that cell counts at P14 are
the same across all conditions supports the hypothesis that the
developing brain has the ability to compensate for at least some
anesthetic-induced developmental stress.
Several studies support the theory that plasticity in the hip-
pocampal DG may compensate for neuronal injury. The SGZ of
the DG is an ongoing source of neurogenesis, even in adulthood,
presumably providing neuroplasticity to the hippocampus
(Drew et al., 2013; Stratmann et al., 2009a, 2014). For example,
neurogenesis in the developing DG is increased by brain insults
which include cerebral ischemia (Kim et al., 2015), traumatic
brain injury (Sun et al., 2015), and early life stress (Naninck et al.,
2015). However, other insults, including ethanol exposure
(Broadwater et al., 2014), radiation exposure (Roughton et al.,
2012), and a 4-h isoflurane exposure (Stratmann et al., 2009b),
decreased neurogenesis in the developing DG. This 4-h expo-
sure to isoflurane also impaired adult spatial learning and
memory in the MWM (Stratmann et al., 2009b). The fact that we
detected only a transient decrease in BrdU-positive cell num-
bers in the DG and no cognitive deficit may therefore be because
of a shorter, 2-h exposure, which presumably allowed neuro-
genesis to resume. Taken together, these data suggest that
ongoing DG neurogenesis may be a compensatory mechanism
for early anesthetic-induced changes.
We found that different anesthetics can have distinct neuro-
modulatory profiles. For example, isoflurane and desflurane
caused a transient impairment of neuronal development in the
hippocampus, whereas sevoflurane did not. Interestingly, iso-
flurane and desflurane belong to the same methyl–ethyl ether
chemotype (with only one atom difference), whereas sevoflur-
ane is a methyl–isopropyl ether. Others have also detected dif-
ferences between sevoflurane and desflurane (Shen et al., 2013),
and between sevoflurane and isoflurane (Liang et al., 2010).
FIG. 5. Morris water maze results at 6 months after anesthetic exposure. There was no significant interaction between anesthetic groups and controls for the (A) escape
latencies for the cued training trials, (B) escape latencies for place trials, (C) probe test, or (D) swim speeds. Data are expressed as means 6 SEM; n¼12 for each group.
(Con¼ control, Iso¼ isoflurane, Sevo¼ sevoflurane, Des¼desflurane.).
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Support for distinct mechanistic differences between these oth-
erwise similar drugs is evident in recent in vitro work that
revealed a novel activation of voltage-gated Kþchannels by sev-
oflurane, but not by isoflurane or desflurane (Barber et al., 2012).
Although it is difficult to predict the cognitive and behavioral
consequences of a transient alteration in neuronal develop-
ment, it seems most reasonable to anticipate a subtle, if any,
effect. Accordingly, we detected small but significant changes in
spatial learning curves 6 weeks after isoflurane exposure, as
well as an impairment on day 3 of the MWM testing after iso-
flurane and desflurane exposure. However, there were no sig-
nificant changes in MWM performance at 6 months after
anesthetic exposure. The long-term behavioral results for all
three anesthetics are consistent with those of another recent
study, in which a 30-min sevoflurane exposure on P7 or P15 was
not found to result in memory deficits at 3 months post-
exposure (Qiu et al., 2016). Our results support the idea that
subtle developmental changes induced by anesthetic exposure
may not result in detectable long-term neurobehavioral
consequences.
Many human retrospective studies have suggested that mul-
tiple anesthetic exposures may result in subsequent cognitive
dysfunction, and this has been reproduced in some animal
studies (Shen et al., 2013; Zhu et al., 2010). When P14 rodents
were exposed to isoflurane for 35 min for four consecutive days,
they showed a memory deficit as well as fewer hippocampal
stem and granule cells (Zhu et al., 2010). In another study, P6
rodents exposed to 3% sevoflurane for 2 h on three consecutive
days developed cognitive impairment and increased levels of
neuroinflammatory markers, but a single 2-h exposure had no
such effects (Shen et al., 2013). The same study also found no
significant effects on cognition after a single 2 h or multiple
exposures to 9% desflurane (Shen et al., 2013). Another study
examined the effects of exposing P7 rat pups to a single 1.8%
isoflurane exposure for 2 h compared with three 2-h exposures,
3 days apart. They found that the rats exposed to three 2-h
exposures had cognitive deficits at 3 months of age (Murphy
and Baxter, 2013). Thus, these studies conclude that a single
short exposure does not typically cause long-term damage. The
changes seen in neuronal development after either single or
multiple anesthetic exposures in animals could be related to
the total MAC-hours of exposure, or to accumulated physiologi-
cal derangements in rodent studies that were sub-optimally
monitored and poorly controlled.
The recently published results of two human clinical trials
also support our results. The ongoing GAS study, which com-
pared neurodevelopmental outcomes in infants undergoing
inguinal herniorrhaphy who were randomly assigned to receive
awake-regional anesthesia or general anesthesia using sevo-
flurane, found no differences in neurodevelopmental outcome
at 2 years of age (Davidson et al., 2016). The PANDA study, which
compared the IQ scores of children exposed to general anesthe-
sia during inguinal herniorrhaphy under age 3 years with the IQ
scores of an unexposed sibling, also found that a single expo-
sure to general anesthesia resulted in no differences in IQ
scores later in childhood (Sun et al., 2016).
Our study has several limitations. First, both the control and
experimental animals were separated from their mothers dur-
ing the exposure, which is common practice and considered a
control for maternal separation (Jevtovic-Todorovic et al., 2003;
Liang et al., 2010; Murphy and Baxter, 2013; Peng et al., 2014; Qiu
et al., 2016; Sanchez et al., 2011; Shen et al., 2013; Shih et al., 2012;
Stratmann et al., 2009a,b; Yang et al., 2014). However, it has
recently been proposed that maternal separation may be more
stressful for the conscious control animals than for the anesthe-
tized experimental group, possibly creating long-term behavio-
ral changes in the control animals, primates in particular (Raper
et al., 2016). Given that there was no significant difference
between the control and experimental groups, the effect is prob-
ably subtle in our study. Secondly, although our postnatal day 2
rat pups were not physiologically monitored by objective inva-
sive measures, the similarity between the groups suggests that
any untoward physiological derangements did not have had
large overall effects on our results. Furthermore, blind cardiac
puncture for arterial collection is unreliable, and other means of
obtaining arterial blood should be explored in such young rat
pups. Finally, our rat pups were sacrificed immediately after the
exposures and not enough time may have elapsed to detect the
maximum amount of apoptosis at P2.
In conclusion, our results indicate that a single 2-h exposure
at P2 to isoflurane, desflurane, or sevoflurane yields no long-
term behavioral deficits as evidenced by MWM performance.
Isoflurane and desflurane, but not sevoflurane, transiently dis-
rupt brain development and subsequent cognitive function.
However, further investigation is warranted to identify the
exact mechanisms underlying this disruption. While these data
indicate reversibility and an absence of cognitive consequences
after a single exposure to one of three volatile anesthetics,
future studies are needed to discover the threshold dose and
duration at which the neuromodulatory effect becomes irrever-
sible for each anesthetic. Children will continue to require gen-
eral anesthesia for surgery and procedures, so we must
determine the safest possible way to provide it.
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